+44 (0)1509 263171
Please use this identifier to cite or link to this item:
|Title: ||Contrast-enhanced spectral mammography: what is the 'added value' in a symptomatic setting? Initial findings from a UK centre|
|Authors: ||Tennant, Sarah L.|
Cornford, Eleanor J.
Burrell, Helen C.
Hamilton, Lisa J.
|Issue Date: ||2015|
|Publisher: ||BioMed Central (© the authors)|
|Citation: ||TENNANT, S. ... et al., 2015. Contrast-enhanced spectral mammography: what is the 'added value' in a symptomatic setting? Initial findings from a UK centre [poster]. IN: Proceedings of 2015 British Society of Breast Radiology Annual Scientific Meeting, Nottingham, Great Britain, 9-11 November 2015, poster no. 14.|
|Abstract: ||Contrast-enhanced spectral mammography (CESM) is a new technology. Dual energy acquisitions during one exposure yield two sets of images: a low energy (LE) set, equivalent to standard full field digital mammography (FFDM); and a recombined set displaying contrast uptake. In our symptomatic breast service, specific patients, including those with a P4/5 clinical abnormality are offered CESM instead of FFDM. Despite encouraging data from Europe and the USA, there are, until now, no UK data to support its use in this setting.|
|Description: ||An abstract of this presentation was published as: TENNANT, S. ... et al., 2015. Contrast-enhanced spectral mammography: what is the 'added value' in a symptomatic setting? Initial findings from a UK centre. Breast Cancer Research, 17 (Suppl. 1), p.6, DOI: 10.1186/bcr3776.|
|Version: ||Accepted for publication|
|Publisher Link: ||http://dx.doi.org/10.1186/bcr3776|
|Appears in Collections:||Conference Papers and Presentations (Computer Science)|
Files associated with this item:
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.